These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24842634)

  • 21. The present volume is base on the "Integrating Systems Approaches into Pharmaceutical Sciences" conference held in Basel in 2007. Preface.
    Goryanin I; Lebedeva G
    Eur J Pharm Sci; 2009 Jan; 36(1):1-3. PubMed ID: 19038334
    [No Abstract]   [Full Text] [Related]  

  • 22. Ligand-based approaches to in silico pharmacology.
    Vidal D; Garcia-Serna R; Mestres J
    Methods Mol Biol; 2011; 672():489-502. PubMed ID: 20838981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacometrics meets statistics-A synergy for modern drug development.
    Ryeznik Y; Sverdlov O; Svensson EM; Montepiedra G; Hooker AC; Wong WK
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1134-1149. PubMed ID: 34318621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspective on the State of Pharmacometrics and Systems Pharmacology Integration.
    Trame MN; Riggs M; Biliouris K; Marathe D; Mettetal J; Post TM; Rizk ML; Visser SAG; Musante CJ
    CPT Pharmacometrics Syst Pharmacol; 2018 Oct; 7(10):617-620. PubMed ID: 29761892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A rational drug prescription based upon the therapeutic process].
    Carrillo Norte JA
    Rev Enferm; 2010 Feb; 33(2):28-32. PubMed ID: 20387410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Future prospects for the relationship between pharmacological studies and good laboratory practice].
    Kuranami J
    Nihon Yakurigaku Zasshi; 2012 Mar; 139(3):109-12. PubMed ID: 22451465
    [No Abstract]   [Full Text] [Related]  

  • 27. Alternatives to structural modeling.
    Veng-Pedersen P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():49-50. PubMed ID: 9003579
    [No Abstract]   [Full Text] [Related]  

  • 28. Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.
    Koukouritaki SB; Hines RN
    Pharmacogenomics; 2005 Dec; 6(8):807-22. PubMed ID: 16296944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New technologies for application to veterinary therapeutics.
    Riviere JE
    Handb Exp Pharmacol; 2010; (199):191-210. PubMed ID: 20204588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Publishing pharmacology in the twenty-first century.
    Bloom FE
    Proc West Pharmacol Soc; 2000; 43():93-4. PubMed ID: 11056967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model organisms and new tools: choose your weapons wisely.
    Ecker DJ; McAlpine J; Culver K
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):159-60. PubMed ID: 12669449
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural products in drug discovery.
    Harvey AL
    Drug Discov Today; 2008 Oct; 13(19-20):894-901. PubMed ID: 18691670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings.
    Barrett JS; Fossler MJ; Cadieu KD; Gastonguay MR
    J Clin Pharmacol; 2008 May; 48(5):632-49. PubMed ID: 18440922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacometrics at FDA: evolution and impact on decisions.
    Powell JR; Gobburu JV
    Clin Pharmacol Ther; 2007 Jul; 82(1):97-102. PubMed ID: 17538553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: impact on research in pharmacology. Introduction.
    Levine RJ
    Fed Proc; 1977 Sep; 36(10):2341-3. PubMed ID: 330250
    [No Abstract]   [Full Text] [Related]  

  • 36. Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview.
    Atkinson AJ; Lalonde RL
    Clin Pharmacol Ther; 2007 Jul; 82(1):3-6. PubMed ID: 17571065
    [No Abstract]   [Full Text] [Related]  

  • 37. A cost-effectiveness approach to the qualification and acceptance of biomarkers.
    Williams SA; Slavin DE; Wagner JA; Webster CJ
    Nat Rev Drug Discov; 2006 Nov; 5(11):897-902. PubMed ID: 17080026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactive visualization and communication for increased impact of pharmacometrics.
    Krause A; Gieschke R
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):140S-145S. PubMed ID: 20881227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationships of the American Society for Clinical Pharmacology and Therapeutics to government.
    Finkel MJ
    Clin Pharmacol Ther; 1990 Feb; 47(2):287-90. PubMed ID: 2406086
    [No Abstract]   [Full Text] [Related]  

  • 40. Veterinary pharmacology: a look into the future.
    Mills PC; Higgins A
    Vet J; 2007 Nov; 174(3):447-8. PubMed ID: 17967554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.